These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6163712)

  • 1. Immunochemical properties of Vi antigen from Salmonella typhi Ty2: presence of two antigenic determinants.
    Szewczyk B; Taylor A
    Infect Immun; 1980 Aug; 29(2):539-44. PubMed ID: 6163712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of Vi-related antigens in the microcapsule of Salmonella typhi.
    Szewczyk B; Taylor A
    Infect Immun; 1980 Dec; 30(3):661-7. PubMed ID: 6164644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and immunochemical properties of Escherichia coli B polysaccharide cross-reacting with Salmonella typhi Vi antigen: preliminary evidence for cross-reaction of the polysaccharide with Escherichia coli K1 antigen.
    Szewczyk B; Taylor A
    Infect Immun; 1983 Jul; 41(1):224-31. PubMed ID: 6345392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysaccharides and their common proteinic carrier in the Vi antigens of Citrobacter ballerup and Salmonella typhi Ty2.
    Barber C
    Microbios; 1981; 32(128):71-6. PubMed ID: 6176838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective properties of Vi-antigen preparations as dependent on their adhesin content].
    Alliluev AP; Kotel'nikova OV; Korneeva SA; Fish NG; Kulinich LI
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):21-6. PubMed ID: 2469269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunochemical characteristics of artificial antigens with Salmonella O-determinants 4 and 9].
    Pokrovskiĭ VI; Tendetnik IuIa; Pokrovskiĭ VV; Cherniak AIa; Levinskiĭ AB
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):69-72. PubMed ID: 6084378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serological specificities of Salmonella typhi antigens.
    Barber C; Eylan E
    Microbios; 1976; 16(64):125-31. PubMed ID: 69247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a human monoclonal immunoglobulin M (IgM) antibody (IgMBEN) specific for Vi capsular polysaccharide of Salmonella typhi.
    Liao J; Nickerson KG; Bystricky S; Robbins JB; Schneerson R; Szu SC; Kabat EA
    Infect Immun; 1995 Nov; 63(11):4429-32. PubMed ID: 7591081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
    Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
    PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Presence of specific sites on the complete antigen O (Boivin antigen) of Salmonella typhi].
    Nivet C; Staub AM
    C R Acad Hebd Seances Acad Sci D; 1972 May; 274(20):2815-8. PubMed ID: 4625388
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement of the indirect hemagglutination assay for Salmonella typhi Vi antibodies by use of glutaraldehyde-fixed erythrocytes.
    Barrett TJ
    J Clin Microbiol; 1985 Oct; 22(4):662-3. PubMed ID: 3935664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study and preparation of Vi-PHA reagent and its application for detection of Salmonella typhi carriers].
    Bao X; Qiu J; Yang N; Mei L; Chen X
    Wei Sheng Wu Xue Bao; 1992 Aug; 32(4):289-95. PubMed ID: 1413737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Vi passive hemagglutination test in the sera of S. typhi carriers. I. Evaluation of 3 preparations of Vi antigen and O antigen].
    Blośnicka R
    Przegl Epidemiol; 1974; 28(4):447-52. PubMed ID: 4475446
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a.
    Cryz SJ; Fürer E; Baron LS; Noon KF; Rubin FA; Kopecko DJ
    Infect Immun; 1989 Dec; 57(12):3863-8. PubMed ID: 2807550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunochemical study of the antigenic complexes from typhoid-paratyphoid A and B bacteria obtained industrially].
    Khatuntseva NV; Mironova MV; Riapolova RG; Rybasova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):50-5. PubMed ID: 4409774
    [No Abstract]   [Full Text] [Related]  

  • 16. The Vi antigen of Salmonella typhi: molecular analysis of the viaB locus.
    Kolyva S; Waxin H; Popoff MY
    J Gen Microbiol; 1992 Feb; 138(2):297-304. PubMed ID: 1564441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory effect of Salmonella VI-antigen in serologic reactions based on active and passive hemagglutination].
    Basova NN; Pravdiuk EG; Biĭchaninova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Apr; (4):103-5. PubMed ID: 7405450
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutralization reaction of bacteriolysins and its application for the titration of salmonella O antigens.
    Tendetnik YY; Levi MI; Rukhadze EZ; Vydrina EI; Pryamukhina NS
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):104-13. PubMed ID: 4575461
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunologic properties and role of the low-molecular component in a preparation of S. typhi Vi antigen].
    Aleksander SK; Liashenko VA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):28-32. PubMed ID: 1154936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic basis of Vi antigen expression in Salmonella paratyphi C.
    Snellings NJ; Johnson EM; Baron LS
    J Bacteriol; 1977 Jul; 131(1):57-62. PubMed ID: 68953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.